Innovative Pricing and Payment Models for Health Technologies

By João L. Carapinha

October 22, 2024

The article titled “Design and Features of Pricing and Payment Schemes for Health Technologies,” centers on the crucial topic of pricing and payment (P&P) schemes for health technologies in the healthcare sector. The discussion encompasses key aspects that influence this domain, providing insights on how these schemes can effectively address current challenges.

Objective

The article aims to map existing types of pricing and payment schemes for health technologies while proposing a new, flexible, need-driven classification system that enhances understanding and applicability.

Context

Given the increasing clinical and financial uncertainty in the healthcare sector, innovative pricing and payment schemes are being explored as potential solutions to these persistent challenges.

Current Schemes

The article conducts a scoping review to identify and categorize the various P&P schemes currently in use for health technologies. This includes different models such as:

  • Fixed pricing
  • Value-based pricing
  • Risk-sharing agreements
  • Pay-for-performance models
  • Subscription-based models

Proposed Classification

The authors propose a new classification system that is both flexible and need-driven. This system is designed to help policymakers, healthcare providers, and manufacturers navigate the complex landscape of P&P schemes more effectively. It considers various factors, including the type of health technology and the specific needs of different healthcare systems.

Key Features

The article highlights several key features of effective pricing and payment schemes, which include:

  • Flexibility: The ability to adapt to evolving healthcare needs and financial constraints.
  • Value-Based: Schemes that tie payments to actual health outcomes or to the value delivered by the health technology.
  • Risk Management: Mechanisms that distribute risk among manufacturers, payers, and providers.
  • Innovation Incentives: Schemes designed to encourage the development and adoption of new health technologies.

Implications

The proposed classification and analysis of P&P schemes have significant implications for healthcare policy, practice, and research. It can aid in:

  • Improving the sustainability of healthcare systems
  • Enhancing access to innovative health technologies
  • Aligning payments with health outcomes
  • Reducing financial uncertainty for various stakeholders involved.

In summary, the article provides a comprehensive framework for understanding and improving the design and implementation of P&P schemes in the healthcare sector, ultimately serving as a vital tool in addressing current challenges. The focus on pricing and payment schemes is essential for fostering effective health technology utilization and ensuring ongoing innovation.

Reference url

Recent Posts

HERNEXEOS Lung Cancer Treatment: First FDA Approval for HER2-Mutant NSCLC

By HEOR Staff Writer

March 2, 2026

FDA Greenlights HERNEXEOS Lung Cancer Treatment as First-Line Option HERNEXEOS lung cancer treatment (zongertinib tablets), developed by
KEYTRUDA Padcev MIBC Survival: New Era in Treatment Revealed by KEYNOTE-B15 Trial Results
KEYTRUDA Padcev MIBC Survival Breakthrough in Cisplatin-Eligible Patients KEYTRUDA Padcev MIBC Survival benefits shone in the Phase 3 KEYNOTE-B15 trial, where perioperative KEYTRUDA (pembrolizumab) plus Padce...
Novartis Drug Discovery Innovation: Advancing Global Health Through Strategic R&D

By João L. Carapinha

February 26, 2026

Novartis drug discovery innovation is transforming global health through the Biomedical Research group's shift from siloed efforts to an integrated, patient-centric model targeting high-burden diseases in low- and middle-income countries (LMICs). Under Manju Ujjini, Head of Lead Discovery, key mi...